Clinical Trials Logo

Filter by:
NCT ID: NCT02828358 Active, not recruiting - Clinical trials for Mixed Phenotype Acute Leukemia

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

Start date: April 1, 2017
Phase: Phase 2
Study type: Interventional

This pilot phase II trial studies the side effects of azacitidine and combination chemotherapy in infants with acute lymphoblastic leukemia and KMT2A gene rearrangement. Drugs used in chemotherapy, such as methotrexate, prednisolone, daunorubicin hydrochloride, cytarabine, dexamethasone, vincristine sulfate, pegaspargase, hydrocortisone sodium succinate, azacitidine, cyclophosphamide, mercaptopurine, leucovorin calcium, and thioguanine work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug may kill more cancer cells.

NCT ID: NCT02944201 Active, not recruiting - Prostate Cancer Clinical Trials

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Start date: April 1, 2017
Phase: Phase 2
Study type: Interventional

This will be a single arm, window of opportunity study in men with treatment-naïve prostate cancer who will proceed to prostatectomy. Men will be treated with carvedilol prior to undergoing prostatectomy.

NCT ID: NCT02976025 Active, not recruiting - Clinical trials for Perinatal Depression

Remote Supervision for Implementing Collaborative Care for Perinatal Depression

MInD-I
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study evaluates the impact of a longitudinal remote consultation (LRC) implementation strategy for collaborative care depression treatment among perinatal women. All participating health centers will receive training in collaborative care. Cluster randomization will be used to assign the addition of LRC to select health centers. Differences in implementation success, clinical outcomes, and costs will be compared after a 12 month implementation period and 13-21 month sustainment period.

NCT ID: NCT03018132 Active, not recruiting - Depression Clinical Trials

Preeclampsia Research on Vitamin D, Inflammation, & Depression

PROVIDE
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study is designed to comprehensively investigate the anti-inflammatory role of vitamin D in reproductive aged women, and its association with preeclampsia and depression. Findings will have substantial impact providing new information implicated in the development of preeclampsia (a condition that may include hypertension, tissue swelling caused by excessive fluid, and kidney stress) and postpartum depression (after birth). Additionally, the study is designed to understand how early mental health screening and evaluation can help pregnant women reduce their risk of developing postpartum depression. Testing the acceptability and effectiveness of this mental health screening, education and referral program at Cedars-Sinai Medical Center will provide valuable patient centered qualitative and quantitative data that can be used in future services planning. The study will enroll up to 200 pregnant women (in third trimester of pregnancy) in total.

NCT ID: NCT03035123 Active, not recruiting - Heart Failure Clinical Trials

Therapeutic Education Strategy for Patients With Acute Heart Failure

EduStra-HF
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The EduStra-HF study will examine the impact of an intensive therapeutic education on patients discharged from hospital after an episode of acute heart failure (HF). Patients will be randomized into two groups: one will receive "usual care" monitoring and one will receive a specific educational monitoring programme for 1 year. All patients will meet with a specialized therapeutic education nurse before discharge. The effect of the intensive education on HF rehospitalization and quality of life will be examined.

NCT ID: NCT03051282 Active, not recruiting - Healthy Volunteers Clinical Trials

Genetic Determinants of ACEI Prodrug Activation

Start date: April 1, 2017
Phase: Phase 4
Study type: Interventional

Angiotensin-converting enzyme inhibitors (ACEIs) are among the most frequently prescribed medications worldwide for the treatment of essential hypertension, left ventricular systolic dysfunction, acute myocardial infarction, and prevention of the progression of diabetic nephropathy. However, the outcome of ACEI treatment varies significantly between individuals and selected populations. Suboptimal response, therapeutic failure, and significant side effects are commonly documented in patients receiving ACEI therapy. Approximately 80% of the ACEIs available for use in the US are synthesized as esterified prodrugs in order to improve otherwise poor oral bioavailability of the active molecule. The activation of ACEI prodrugs primarily occurs in the liver via metabolic de-esterification of the parent drug. The critical activation step is essential in delivering a successful therapeutic outcome since the active metabolites are approximately 10-1000 times more potent relative to their respective parent compounds. Carboxylesterase 1 (CES1), the most abundant hydrolase in the liver, is responsible for the activation of ACEI prodrugs in humans. Marked interindividual variability in CES1 expression and activity has been documented, which results in varied therapeutic efficacy and tolerability of many drugs serving as substrates of CES1. Genetic variation of CES1 is considered to be a major factor contributing to variability in CES1 function. The study team proposes to conduct a multiple-dose healthy volunteer study to evaluate the impact of CES1 genetic variation on the activation, pharmacokinetics, and pharmacodynamics of enalapril, a model ACEI prodrug activated by CES1. The completion of this study will represent a major step towards the establishment of an evidence base from which a more individualized use of ACEI prodrugs can emerge.

NCT ID: NCT03077061 Active, not recruiting - Peri-Implantitis Clinical Trials

Peri-implantitis - Reconstructive Surgical Therapy

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The project will evaluate the potential benefit of the use of bone replacement graft as an adjunct to surgical therapy of peri-implantitis. The project will be conducted as a two-armed randomized controlled clinical trial of 5-year duration in 7 clinical centers. 140 systemically healthy patients diagnosed with peri-implantitis will randomly assigned to be treated with or without bone replacement graft. Outcome measures include assessments of inflammation, probing depth, recession, radiological parameters and PROMs.

NCT ID: NCT03081390 Active, not recruiting - Migraine Clinical Trials

Migraine and CVD Risk in Women

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The primary goal of this study is to test the effects of a high-fat, high-carbohydrate mixed meal on candidate modulators of cardiovascular disease risk (inflammation, vascular reactivity, sympathetic nervous system tone, and response to pain) in young adult women with migraine compared with healthy young women. This is study enrolling both cases (women with migraine) and controls (women without migraine), with equal numbers of normal weight and obese women in each group. Participants will undergo a telephone screening and a single day in-person study visit.

NCT ID: NCT03099434 Active, not recruiting - Kidney Diseases Clinical Trials

Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media

ENGAGE
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This pilot study will be a clinical trial to test the feasibility and effectiveness of an educational intervention and a mobile health intervention in adults with end stage renal disease (ESRD) who have not yet identified a potential live donor.

NCT ID: NCT03111563 Active, not recruiting - Hysteroscopy Clinical Trials

Effectiveness of Warm Saline Distension Media on Relieving Pain in Office Hysteroscopy

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The aim of the study is to compare the effectiveness of warm saline distension media versus room temperature saline distension media on relieving pain in office hysteroscopy .